Johnson & Johnson Sees Heavy Put Buying at $230 Even as Stock Climbs 1.71%

By TrendSpider Editor

Johnson & Johnson attracted significant unusual options activity Tuesday, with bearish put contracts accounting for the bulk of a $1,724,680 total premium across four flagged trades, even as shares gained 1.71% to $235.225. The two largest contracts were puts at the $230 strike, combining for $1,589

Johnson & Johnson Sees Heavy Put Buying at $230 Even as Stock Climbs 1.71%

Johnson & Johnson attracted significant unusual options activity Tuesday, with bearish put contracts accounting for the bulk of a $1,724,680 total premium across four flagged trades, even as shares gained 1.71% to $235.225. The two largest contracts were puts at the $230 strike, combining for $1,589,375 in premium and suggesting at least some institutional players are hedging against or betting on a near-term pullback. With JNJ currently sitting closer to its 52-week high of $251.705 than its 52-week low of $150.02, the stock has had a strong run, making the put activity worth monitoring.

Key Drivers of the JNJ Stock Move

The forward setup for JNJ is a study in conflicting signals. The near-term put positioning at $230 could reflect portfolio hedging by large holders given how far the stock has rallied from its 52-week low of $150.02 rather than an outright directional bet. At the same time, the long-dated December 2028 call at the $240 strike, while small in size at 11 contracts, signals that at least one participant sees meaningful upside over the next two and a half years. JNJ has faced ongoing legal and operational headlines in recent years, and any developments on that front could quickly shift sentiment. Traders should watch whether the $230 put activity grows in the sessions ahead or was a one-day positioning event.

JNJ Unusual Options Activity

Total unusual contracts flagged: 4. Total premium across all contracts: $1,724,680. Put contracts accounted for the clear majority of premium activity, with both positioned out of the money at the $230 strike below the current price of $235.225.

JNJ Seasonality

Late June has historically been a mixed period for large-cap healthcare names as investors reposition ahead of mid-year portfolio reviews and the July earnings season begins to approach. With JNJ's next earnings cycle likely falling in mid-July, the short-dated July 17 put contract expiring just days after a likely reporting date adds a layer of event-driven significance to today's flow.

JNJ Relative Performance

JNJ's 1.71% gain on Tuesday positions it as an outperformer relative to many large-cap peers on the session. Trading at $235.225, the stock sits well above its 52-week low of $150.02 and within striking distance of its 52-week high of $251.705, placing it in the upper portion of its annual range and reflecting the broader resilience seen across defensive healthcare names in 2026.

More on JNJ

Latest Market News